Lee Ainslie’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.12M Buy
+34,008
New +$2.15M 0.02% 98
2021
Q2
– Sell
-40,241
Closed -$2.54M – 686
2021
Q1
$2.54M Buy
40,241
+17,692
+78% +$1.1M 0.02% 131
2020
Q4
$1.4M Buy
22,549
+15,382
+215% +$946K 0.02% 184
2020
Q3
$432K Sell
7,167
-58,206
-89% -$3.5M 0.01% 431
2020
Q2
$3.84M Sell
65,373
-3,580
-5% -$214K 0.08% 73
2020
Q1
$3.84M Sell
68,953
-46,300
-40% -$2.83M 0.08% 106
2019
Q4
$7.4M Sell
115,253
-9,259
-7% -$530K 0.11% 83
2019
Q3
$6.31M Buy
124,512
+3,512
+3% +$165K 0.09% 98
2019
Q2
$5.49M Sell
121,000
-17,060
-12% -$795K 0.08% 143
2019
Q1
$6.59M Buy
+138,060
New +$6.88M 0.09% 137
2018
Q4
– Sell
-148,610
Closed -$9.23M – 262
2018
Q3
$9.23M Buy
+148,610
New +$8.82M 0.11% 83

Other funds holding BMY

Lee Ainslie's BMY Position: Q3 2026 in Review

Lee Ainslie opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 34,008 shares worth $2.12M. The stake represents 0.02% of the portfolio and ranks #98 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in BMY as recently as Q1 2021.

Lee Ainslie first reported a position in BMY in Q3 2018 and has held it in 11 quarters since. The position peaked at $9.23M in Q3 2018. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Lee Ainslie held 34,008 shares of Bristol-Myers Squibb worth $2.12M as of Q3 2026.
  • Bristol-Myers Squibb was a new Lee Ainslie position in Q3 2026.
  • Bristol-Myers Squibb made up 0.02% of Lee Ainslie's portfolio in Q3 2026, its #98 holding.
  • Lee Ainslie first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 11 quarters since.
  • Lee Ainslie's Bristol-Myers Squibb position peaked at $9.23M in Q3 2018.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.